Tsuboi Akihiro | Department Of Cancer Immunotherapy Osaka University Graduate School Of Medicine
スポンサーリンク
概要
- TSUBOI Akihiroの詳細を見る
- 同名の論文著者
- Department Of Cancer Immunotherapy Osaka University Graduate School Of Medicineの論文著者
関連著者
-
Tsuboi Akihiro
Department Of Cancer Immunotherapy Osaka University Graduate School Of Medicine
-
Tsuboi Akihiro
東北大学 医学系研究科血液病理学分野
-
OJI Yusuke
Departments of Clinical Laboratory Science
-
SUGIYAMA Haruo
Departments of Clinical Laboratory Science
-
Oji Yusuke
Department Of Functional Diagnostic Science Osaka University Graduate School Of Medicine
-
Sugiyama Haruo
Department Of Clinical Laboratory Science Osaka University Medical School
-
Hiraoka Sakamaki
Department Of Hematology Tokyo Metropolitan Komagome Hospital
-
Saito H
Nagoya Central Hospital
-
Soda Hisashi
Department Of Hematology Tokyo Metropolitan Komagome Hospital
-
Soda Hisashi
Department Of Internal Medicine Isahaya Insurance General Hospital
著作論文
- Successful treatment of relapsed T-cell non-Hodgkin's lymphoma with allogeneic peripheral blood stem cell transplantation with double conditioning
- Monitoring Minimal Residual Disease in Leukemia Using Real-time Quantitative Polymerase Chain Reaction for Wilms Tumor Gene (WT1)
- Expression of the Wilms' Tumor Gene WT1 in Solid Tumors and Its Involvement in Tumor Cell Growth
- Sensitive immunohistochemical detection of WT1 protein in tumors with anti-WT1 antibody against WT1 235 peptide
- High frequencies of less differentiated and more proliferative WT1-specific CD8^+ T Cells in bone marrow in tumor-bearing patients : An important role of bone marrow as a secondary lymphoid organ
- Biased usage of BV gene families of T-cell receptors of WT1 (Wilms' tumor gene)-specific CD8^+ T cells in patients with myeloid malignancies
- Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma
- Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors
- Overexpression of the Wilms' tumor gene WT1 in primary thyroid cancer
- Wilms Tumor Gene WT1 Peptide-Based Immunotherapy Induced a Minimal Response in a Patient with Advanced Therapy-Resistant Multiple Myeloma